Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Items 1-10 of 63

Page
per page
  1. CDK9 inhibitor
    A3294 CDK9 inhibitor
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK9 inhibitor
      Soluble in DMSO
  2. CDK inhibitor II
    A3293 CDK inhibitor II
    Summary: CDK inhibitor
      Soluble in DMSO
  3. CDK9 inhibitor 2
    A3295 CDK9 inhibitor 2
    Summary: CDK9 inhibitor
      Soluble in DMSO
  4. Cdk1/2 Inhibitor III
    C3679 Cdk1/2 Inhibitor III
    Summary: Cdk1/cyclin B and Cdk2/cyclin A inhibitor
      ≤10 mg/mL
  5. Cdk4/6 Inhibitor IV
    C3995 Cdk4/6 Inhibitor IV
    Summary: Cdk4/cyclin D1 and Cdk6/cyclin D1 inhibitor
      ≤1 mg/mL
  6. LY2835219 free base
    A3575 LY2835219 free base
    Summary: CDK inhibitor
      insoluble in H2O; ≥4.83 mg/mL
  7. PHA-848125
    A8501 PHA-848125
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor,potent and ATP-competitive
      ≥23.05 mg/mL
  8. LY2857785
    B8002 LY2857785
    Summary: CDK9 inhibitor
  9. Ryuvidine
    B7128 Ryuvidine
    Summary: SETD8 protein lysine methyltransferase (PKMT) inhibitor
      Soluble in DMSO
  10. AZD-5438
    A8326 AZD-5438
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK1/2/9 inhibitor
      insoluble in H2O; ≥18.55 mg/mL

Items 1-10 of 63

Page
per page